A good COVID-19 vaccine is good enough
Photo by Michael Ciaglo/Getty Images Experts have been looking forward to seeing results from Johnson and Johnson’s COVID-19 vaccine trials for months. The vaccine is a logistical dream compared to the other two authorized in the US. It’s much easier to store, and it requires only one shot instead of the two required by its competitors. The only outstanding question was how well it actually worked. On Friday, they got their answer — it works pretty well. A newsletter highlighting the COVID-19 research, developments, and stories that matter. Subscribe here! In a 43,783 person trial that...
Source: theverge.com